$BSGM | Disruptive Technology in Rapidly Growing $4B EP Market
25 May
2016
Written by Mike Elliott

$BSGM | Disruptive Technology in Rapidly Growing $4B EP Market »

In the interview Greg gives an overview of the Electrophysiology or EP Market and talks about its expected growth over the next decade. He also discusses BioSig's partnerships with some of the leading cardiac centers in the country and how the clinical data coming from these partnerships is helping to establish proof-of-concept for PURE EP.

Read more...
$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues
21 Mar
2016
Written by Mike Elliott

$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues »

In this episode of the CEOLIVE.TV Investor Profile Series we interview Dr. Bassam Damaj, CEO of Innovus Pharmaceuticals. Dr. Damaj discusses recent acquisitions, the company's strong commercial pipeline and why Innovus Pharmaceuticals (INNV) is undervalued right now.

Read more...
$CVM | Interview with CEO, Geert Kersten
12 Jan
2016
Written by Mike Elliott

$CVM | Interview with CEO, Geert Kersten »

In this episode of CEOLIVE.TV we talk to Geert Kersten, CEO of CEL-SCI Corp. (NYSE MKT: CVM) who discusses recent updates on the company's Phase 3 FDA Trials as well as what investors can expect for 2016.

Read more...
$ONCS | Next Generation Cancer Vaccines
9 Dec
2015
Written by Mike Elliott

$ONCS | Next Generation Cancer Vaccines »

OncoSec Medical is a biopharmaceutical company developing its investigational ImmunoPulse intratumoral cancer immunotherapy.

Read more...
$NVGN | Promising New Cancer Drug Candidate With Broad Spectrum Potential
4 Sep
2015
Written by Mike Elliott

$NVGN | Promising New Cancer Drug Candidate With Broad Spectrum Potential »

The Themes area has been given a facelift with larger thumbnails, making it easier to quickly browse through your themes. When you click on a theme it displays a screenshot

Read more...
$MBVX CEOLIVE Insider Report | MabVax Therapeutics Holdings
8 Jul
2015
Written by Mike Elliott

$MBVX CEOLIVE Insider Report | MabVax Therapeutics Holdings »

MabVax Therapeutics Holdings, Inc. is cancer diagnostic and immunotherapy company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer.

Read more...

Login

Lost your password?